Welsis (WLSS) Net Equity Issued and Repurchased (2022)

Welsis (WLSS) posted quarterly Net Equity Issued and Repurchased of $20880.0 for Q3 2022, up 1128.24% quarter-over-quarter from $1700.0 in Q2 2022.

Welsis (WLSS) Net Equity Issued and Repurchased (2022) Analysis & Trends

Welsis' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $20880.0 for Q3 2022.

In Q3 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $20880.0; the TTM figure through Jun 2023 stood at $20880.0 (changed N/A YoY), while the FY2022 annual figure was $22580.0, up 11190.0% from the prior year.
Net Equity Issued and Repurchased for Q3 2022 stood at $20880.0, up from $1700.0 in the prior quarter.
The five-year high for Net Equity Issued and Repurchased was $20880.0 in Q3 2022, with the low at $1700.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Welsis	1.65 Mn	1.65 Mn	-	-

Download Data